ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- Long-Term CV Risk of ADHD Treatment in AdultsIs the long-term use of medications used for the treatment of attention-deficit/hyperactivity disorder (ADHD) associated with an increased risk for cardiovascular (CV) outcomes?
- JACC and The Lancet Align to Advance CV HealthJACC and The Lancet are bringing together their resources, expertise, and networks to disseminate high-quality research, foster interdisciplinary collaborations, and advance cardiovascular health worldwide.
- New ACC/AHA Guideline Focuses on Evaluation and Management of People With HCMThe newest clinical guideline, released May 8 by the ACC and the American Heart Association (AHA), provides the latest evidence-based recommendations for effectively managing individuals diagnosed with hypertrophic cardiomyopathy (HCM).
- 2024 AHA/ACC/Multisociety Hypertrophic Cardiomyopathy Guideline: Key PointsThe following are key points to remember from the 2024 AHA/ACC/multisociety guideline for the management of hypertrophic cardiomyopathy (HCM).
- Eagle’s Eye View: The New AHA/ACC Hypertrophic Cardiomyopathy Guideline, Smoking Cessation, Embolic StrokeIn this week’s View, Dr. Eagle looks at the new AHA/ACC Hypertrophic Cardiomyopathy Guideline, then examines a randomized clinical trial that studied smoking cessation after initial treatment failure with varenicline or nicotine.